These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 44471)

  • 1. Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH.
    Nagashima R; Yoshida N
    Arzneimittelforschung; 1979; 29(11):1668-76. PubMed ID: 44471
    [No Abstract]   [Full Text] [Related]  

  • 2. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.
    Yoshida N; Terao N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):78-80. PubMed ID: 6768370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sucralfate, a basic aluminum salt of sucrose sulfate. II. Inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins.
    Nagashima R; Yoshida N; Terao N
    Arzneimittelforschung; 1980; 30(1):73-6. PubMed ID: 6892774
    [No Abstract]   [Full Text] [Related]  

  • 4. Sucralfate, a basic aluminum salt of sucrose sulfate. III. Inhibition of peptic hydrolysis of fibrinogen by sucrose sulfate.
    Terao N; Yoshida N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):76-8. PubMed ID: 6892775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective binding of sucralfate to ulcer lesion. II. Experiments in rats with gastric ulcer receiving 14C-sucralfate or potassium 14C-sucrose sulfate.
    Nagashima R; Hinohara Y; Hirano T; Tohira Y; Kamiyama H
    Arzneimittelforschung; 1980; 30(1):84-8. PubMed ID: 6892777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characteristics of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does basic aluminum sucrose sulfate affect blood coagulability?
    Mcgraw BF; Hesterlee EJ; Gitomer SL; Hollander DH
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):373-6. PubMed ID: 6893754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective binding of sucralfate to gastric ulcer in man.
    Nakazawa S; Nagashima R; Samloff IM
    Dig Dis Sci; 1981 Apr; 26(4):297-300. PubMed ID: 6894571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate.
    Nagashima R; Hinohara Y; Hirano T
    Arzneimittelforschung; 1980; 30(1):88-91. PubMed ID: 6892778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sucralfate protects the ulcer from acids and pepsin].
    von Bocko Polach U
    Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of sucralfate in gastric ulcer and gastritis.
    Sasaki H; Tsunoda Y; Hinohara Y; Nakano H; Miura K; Hirayama C
    Clin Ther; 1983; 5(5):545-57. PubMed ID: 6688556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers.
    Moore JG; Coburn JW; Sanders MC; McSorley DJ; Sirgo MA
    Pharmacotherapy; 1995; 15(6):742-6. PubMed ID: 8602382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sucralfate (Ulcogant). Mechanism of action of a cytoprotective agent].
    Steiner KF
    Fortschr Med; 1983 Dec; 101(46):2153-6 contd. PubMed ID: 6689310
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of sucralfate and its components on acid- and pepsin-induced damage to rat gastric epithelial cells.
    Furukawa O; Matsui H; Suzuki N
    Jpn J Pharmacol; 1997 Sep; 75(1):21-5. PubMed ID: 9334882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor.
    Volkin DB; Verticelli AM; Marfia KE; Burke CJ; Mach H; Middaugh CR
    Biochim Biophys Acta; 1993 Nov; 1203(1):18-26. PubMed ID: 7692970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer.
    McHardy GG
    J Clin Gastroenterol; 1981; 3(Suppl 2):147-52. PubMed ID: 7033351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate.
    Nagashima R; Hirano T
    Arzneimittelforschung; 1980; 30(1):80-3. PubMed ID: 6892776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.